| __timestamp | Galapagos NV | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 2704597 |
| Thursday, January 1, 2015 | 129714000 | 15470000 |
| Friday, January 1, 2016 | 139574000 | 28037000 |
| Sunday, January 1, 2017 | 218502000 | 71615000 |
| Monday, January 1, 2018 | 322876000 | 99828000 |
| Tuesday, January 1, 2019 | 427320000 | 166023000 |
| Wednesday, January 1, 2020 | 523667000 | 201727000 |
| Friday, January 1, 2021 | 491707000 | 259039000 |
| Saturday, January 1, 2022 | 515083000 | 294781000 |
| Sunday, January 1, 2023 | 241294000 | 344077000 |
In pursuit of knowledge
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Galapagos NV and Iovance Biotherapeutics, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D). From 2014 to 2023, Galapagos NV consistently led the charge, with R&D expenses peaking in 2020, nearly doubling their 2014 investment. However, the tide turned in 2023 when Iovance Biotherapeutics, Inc. surged ahead, increasing their R&D spending by over 1,200% since 2014. This shift underscores a strategic pivot by Iovance, emphasizing their commitment to innovation. As these companies continue to push the boundaries of biotechnology, their investments in R&D not only fuel their growth but also pave the way for groundbreaking advancements in healthcare.
Comparing Innovation Spending: Eli Lilly and Company and Galapagos NV
Research and Development: Comparing Key Metrics for Merck & Co., Inc. and Iovance Biotherapeutics, Inc.
Research and Development Investment: Sanofi vs Galapagos NV
Summit Therapeutics Inc. vs Galapagos NV: Strategic Focus on R&D Spending
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
TG Therapeutics, Inc. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Perrigo Company plc vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Galapagos NV
R&D Insights: How Iovance Biotherapeutics, Inc. and Travere Therapeutics, Inc. Allocate Funds
R&D Insights: How Iovance Biotherapeutics, Inc. and Evotec SE Allocate Funds
Wave Life Sciences Ltd. or Galapagos NV: Who Invests More in Innovation?